Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

SHA:600789 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	86.96	112.3	394.62	246.17	138.01	89.1
Depreciation & Amortization	429.43	429.43	401.6	381.13	348.12	307.46
Other Amortization	20.11	20.11	0.41	1.44	1.88	2.25
Loss (Gain) From Sale of Assets	-0.17	-0.17	-153.42	-0.28	-2.83	-0.16
Asset Writedown & Restructuring Costs	0.18	0.18	0.15	-	1	0.68
Loss (Gain) From Sale of Investments	5.29	5.29	7.56	7.2	6.53	3.18
Provision & Write-off of Bad Debts	5.16	5.16	2.52	0.98	8.42	24.39
Other Operating Activities	272.49	109.89	159.56	142.19	163.54	113.83
Change in Accounts Receivable	169.33	169.33	-265.44	-124.56	-516.07	-83.45
Change in Inventory	191.09	191.09	-145.06	7.62	-314.68	-356.13
Change in Accounts Payable	-331.3	-331.3	-7.36	-53.29	614.77	78.61
Change in Other Net Operating Assets	3.35	3.35	0.69	0.45	-	-
Operating Cash Flow	835.43	698.17	402.82	604.01	444.38	177.49
Operating Cash Flow Growth	213.08%	73.32%	-33.31%	35.92%	150.36%	-24.33%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-331.68	-338.86	-279.18	-337.91	-428.36	-488.57
Sale of Property, Plant & Equipment	122.96	104.2	20.31	0.03	0.15	1.34
Divestitures	-	-	-	2.13	-	-
Investment in Securities	1.19	1.19	-	-	-15.82	-42.18
Other Investing Activities	22.57	-	-	-34.03	0.03	-4.99
Investing Cash Flow	-184.96	-233.47	-258.87	-369.78	-444.01	-534.4

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	1,875	1,676	2,179	2,145	2,577
Total Debt Issued	1,624	1,875	1,676	2,179	2,145	2,577
Long-Term Debt Repaid	-	-1,839	-1,814	-2,198	-1,973	-2,144
Total Debt Repaid	-1,949	-1,839	-1,814	-2,198	-1,973	-2,144
Net Debt Issued (Repaid)	-325.24	35.98	-137.41	-18.57	171.81	432.68
Issuance of Common Stock	1,187	1,187	17.36	61.88	41.76	1.98
Common Dividends Paid	-162.89	-166.3	-233.49	-143.73	-139.59	-166.39
Other Financing Activities	98.32	99	164.44	6.5	-79.29	-6.95
Financing Cash Flow	797.02	1,156	-189.1	-93.92	-5.31	261.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-4.06	2.24	10.81	2.7	6.46	0.83
Net Cash Flow	1,443	1,622	-34.34	143.01	1.52	-94.76

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	503.75	359.31	123.64	266.09	16.02	-311.07
Free Cash Flow Growth	1900.13%	190.62%	-53.54%	1561.36%	-	-
Free Cash Flow Margin	8.82%	6.23%	1.98%	4.33%	0.29%	-6.32%
Free Cash Flow Per Share	0.51	0.38	0.14	0.30	0.02	-0.35
Levered Free Cash Flow	749.03	452.7	-278.32	-59	-39.51	-436.35
Unlevered Free Cash Flow	788.26	493.81	-231.21	-9.51	21.77	-395.64

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	152.67	154.41	130.55	231.16	65.86	104.04
Change in Working Capital	15.97	15.97	-410.17	-174.83	-220.3	-363.25

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error